Urodynamix Launches UroNIRS 2000TM Pilot Program With Cardinal Health

Main Category: Urology / Nephrology
Article Date: 09 Oct 2009 - 14:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Urodynamix Technologies Ltd. (TSX VENTURE:URO) announces that it has commenced a pilot sales and marketing program with Cardinal Health for its uroNIRS 2000, an innovative technology for the non-invasive diagnosis of bladder conditions. The 90-day pilot program will be used to by Urodynamix and Cardinal Health to evaluate the viability of adding the uroNIRS 2000 to Cardinal Health's catalogue of offerings to the urology market.

The uroNIRS 2000 provides a real-time, non-invasive evaluation of the bladder function during voiding to aid in the diagnosis of bladder outlet obstruction. The product is approved for sale in the U.S.

Source
Urodynamix Technologies Ltd.

Article adapted by Medical News Today from original press release.
Visit our urology / nephrology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Urodynamix Technologies Ltd.. "Urodynamix Launches UroNIRS 2000TM Pilot Program With Cardinal Health." Medical News Today. MediLexicon, Intl., 9 Oct. 2009. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/166894.php>

APA
Urodynamix Technologies Ltd.. (2009, October 9). "Urodynamix Launches UroNIRS 2000TM Pilot Program With Cardinal Health." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/166894.php.

Please note: If no author information is provided, the source is cited instead.


Urology / Nephrology

Most Popular Articles



Follow Our Urology News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Urology / Nephrology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »